Impact of Helicobacter pylori infection on the humoral immune response to MUC1 peptide in patients with chronic gastric diseases and gastric cancer

Immunological Investigations

Volumn 36, Issue 4, 2007, Pages 371-386

  Klaamas, K ^a   Kurtenkov, O ^a   Von Mensdorff Pouilly, S ^b   Shljapnikova, L ^a   Miljukhina, L ^a   Brjalin, V ^a   Lipping, A ^c  

^a NATIONAL INSTITUTE FOR HEALTH DEVELOPMENT   (Estonia)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c North Estonian Regional Hospital   (Estonia)

Author keywords

Gastric cancer; Gastric mucin; Helicobacter pylori; Immune response; MUC1 antibody

Indexed keywords

BOVINE SERUM ALBUMIN; CAGA PROTEIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M; IMMUNOGLOBULIN M ANTIBODY; MUCIN 1;

ADULT; AGED; ARTICLE; BLOOD DONOR; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOLOGY; HUMAN; HUMAN TISSUE; HUMORAL IMMUNITY; IMMUNOBLOTTING; MAJOR CLINICAL STUDY; MUCOSA INFLAMMATION; PRIORITY JOURNAL; SEROLOGY; STOMACH CANCER; STOMACH DISEASE; STOMACH MUCOSA; TUMOR IMMUNITY; UPREGULATION;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; CA-15-3 ANTIGEN; CHRONIC DISEASE; FEMALE; GASTRIC MUCOSA; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; MIDDLE AGED; STOMACH DISEASES; STOMACH NEOPLASMS;

EID: 34547878363     PISSN: 08820139     EISSN: 15324311     Source Type: Journal    
DOI: 10.1080/08820130601109727     Document Type: Article

References (39)

1. Bhat, N., Gaensbauer, J., Peek, R. M., Bloch, K., Tham, K. T., Blaser, M. J., Perez-Perez, G. (2005). Local and systemic immune and inflammatory responses to Helicobacter pylori strains. Clin. Diagn. Lab. Immunol. 12:1393-1400.
2. Bird, J. C., Bresalier, R. S. (2000). Alterations in gastric mucin synthesis by Helicobacter pylori. World J. Gastroenterol. 6:475-482.
3. Blaser, M. J., Atherton, J. C. (2004). Helicobacter pylori persistence: biology and disease. J. Clin. Invest. 113 (3):321-333.
4. Blomberg, J., Nilsson, I., Anderson, M. (1983). Viral antibody screening system that uses a standardized single dilution immunoglobulin G enzyme immunoassay with multiple antigens. J. Clin. Microbiol. 17:1081-1091.
5. Bon, G. G., Von Mensdorff-Pouilly, S., Kenemans, P., Van Kamp, G. J., Verstraeten, R. A., Hilgers, J., Meijer, S. and Vermorken, J. B. (1997). Clinical and technical evaluation of ACS™BR serum assay of MUC1 gene-derived glycoprotein in breast cancer, and comparison with CA 15-3 assays. Clin. Chem. 43:585-593.
6. Chow, W. H., Blaser, M. J., Blot, W. J., Gammon, M. D., Vaughan, T. L., Risch, H. A., Perez-Perez, G. I., Schoenberg, J. B., Stanford, J. L., Rotterdam, H., West, A. B., Fraumeni, J. F. (1998). An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinioma. Cancer Res. 58:588-590.
7. Crowe, S. E. (2005). Helicobacter infection, chronic inflammation, and the development of malignancy. Curr. Opin. Gastroenterol. 21:32-38.
8. Hamanaka, Y., Suehiro, Y., Fukui, M., Shikichi, K., Imai, K., Hinoda, Y. (2003). Circulating anti-MUC1 IgG antibodies as a favorable prognostic factor for pancreatic cancer. Int. J. Cancer 103(1):97-100.
9. Henrik Siman, J., Forsgren, A., Berglund, G., Floren, C. H. (2001). Helicobacter pylori infection is associated with a decreased risk of developing oesophageal neoplasms. Helicobacter 6:310-316.
10. Hinoda, Y., Nakagawa, N., Nakamura, H., Makiguchi, Y., Itoh, F., Adachi, M., Yabana, T., Imai, K., Yachi, A. (1993). Detection of a circulating antibody against a peptide epitope on a mucin core protein, MUC1, in ulcerative colitis. Immunol. Lett. 35:163-168.
11. Hirasawa, Y., Kohno, N., Yokoyama, A., Kondo, K., Hiwada, K., Miyake, M. (2000). Natural autoantibody to MUC1 is a prognostic indicator for non-small cell lung cancer. Am. J. Resp. Crit. Care Med. 161:589-594.
12. Karsten, U., Serttas, N., Paulsen, H., Danielczyk, A., Goletz, S. (2004). Binding patterns of DTR-specific antibodies reveal a glycosylation-conditioned tumor-specific epitope of the epithelial mucin (MUC1). Glycobiology 14:681-692.
13. Karsten, U., von Mensdorf-Pouilly, S., Goletz, S. (2005). What makes MUC1 a tumor antigen? Tumor Biol. 26:217-220.
14. Klaamas, K., Held, M., Wadström, T., Lipping, A., Kurtenkov, O. (1996). IgG immune response to Helicobacter pylori antigens in patients with gastric cancer as defined by ELISA and immunoblotting. Int. J. Cancer 66:1-5.
15. Klaamas, K., Kurtenkov, O., Brjalin, V., Miljukhina, L., Shljapnikova, L., Engstrand, L. (2002b). Enhanced humoral immune response to tumor-associated T glycotope (Galβ1,3GalNAc) in Helicobacter pylori-infected patients with gastric cancer and non-tumor gastric diseases. Exp. Oncol. 24:38-44.
16. Klaamas, K., Kurtenkov, O., Rittenhouse-Olson, K., Brjalin, V., Miljukhina, L., Shljapnikova, L., Engstrand, L. (2002a). Expression of tumor-associated Thomsen-Friedenreich antigen (T Ag) in Helicobacter pylori and modulation of T Ag specific immune response in infected individuals. Immunol. Invest. 31:191-204.
17. Kocer, B., Soran, A., Kiyak, G., Erdogan, S., Eroglu, A., Bozkurt, B., Solak, C., Cengiz, O. (2004). Prognostic significance of mucin expression in gastric carcinoma. Dig. Dis. Sci. 49:954-964.
18. Kurtenkov, O., Klaamas, K., Mensdorff-Pouilly, S., Miljukhina, L., Shljapnikova, L., Chuzmarov, V. (2007). Humoral immune response to MUC1 and to the Thomsen-Friedenreich (TF) glycotope in patients with gastric cancer: relation to survival. Acta Oncologica. 46:316-323.
19. Lauren P. (1965). The two histological main types of gastric carcinoma. An attempt at a histo-clinical classification. Acta Pathol. Microbiol. Scand. 64:31-49.
20. Lee, H. S., Lee, H. K., Kim, H. S., Yang, H. K., Kim, Y. I., Kim, W. H. (2001). MUC1, MUC2, MUC5AC, and MUC6 expressions in gastric carcinoma: their roles as prognostic indicators. Cancer 92:1427-1434.
21. Lelwala-Guruge, J., Schalen, C., Nilsson, I., Ljungh, A., Tyszkiewicz, T., Wikander, M., Madström, T. (1990). Detection of antibodies to Helicobacter pylori cell surface antigens. Scand. J. Infect. Dis. 22:457-465.
22. Macarthur, M., Hold, G. L., El-Omar, E. M. (2004). Inflammation and cancer II. Role of chronic inflammation and cytokine gene polymorphisms in the pathogenesis of gastrointestinal malignancy. Am. J. Physiol. Gastrointest. Liver Physiol. 286:G515-G520.
23. Peek, R. M., Blaser, M. J. (2002). Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat. Rev. Cancer 2:28-37.
24. Rad, R., Prinz, C., Neu, B., Neuhofer, M., Zeitner, M., Voland, P., Becker, I, Schepp, W., Gerard, M. (2003). Synergistic effect of Helicobacter pylori virulence factors and interleukin-1 polymorphisms for the development of severe histological changes in the gastric mucosa. J. Infect. Dis. 188:272-281.
25. Sheu, B. S., Shiesh, S. C., Yang, H. B., Chen, C. Y., Lin, X. Z. (1997). Implications of Helicobacter pylori serological titer for the histological severity of antral gastritis. Endoscopy 29:27-30.
26. Slomiany, B. L., Slomiany, A. (2005). Up-regulation in endothelin-1 by Helicobacter pylori lipopolysaccharide interferes with gastric mucin synthesis via epidermal growth factor receptor transactivation. Scand. J. Gastroenterol. 40:921-928.
27. Snijdewint, F. G. M., von Mensdorff-Pouilly, S., Karuntu-Wanamarta, A. H., Verstraeten, A. A., Livingstone, P. O., Hilgers, J., Kenemans, P. (2001). Antibody-dependent cell-mediated cytotoxicity can be induced by MUC1 peptide vaccination of breast cancer patients. Int. J. Cancer 93:97-101.
28. Sobin, L. H., Wittekind, C. H. (1997). TNM Classification of Malignant Tumors. UICC. Wiley: New York.
29. Tanaka, S., Mizuno, M., Maga, T., Yoshinaga, F., Tomoda, J., Nasu, J., Okada, H., Yokota, K., Oguma, K., Shiratori, Y., Tsuji, T. (2003). H. pylori decreases gastric mucin synthesis via inhibition of galactosyltransferase. Hepatogastroenterology 50(53):1739-1742.
30. Taylor-Papadimitriou, J., Burchell, J., Miles, D. W., Dalziel, M. (1999). MUC1 and cancer. Biochim. Biophys. Acta 1455:301-313.
31. Teixeira, A., David, L., Reis, C. A., Costa, J., Sobriho-Simoes, M. (2002). Expression of mucins (MUC1, MUC2, MUC5AC, and MUC6) and type 1 Lewis antigens in cases with and without Helicobacter pylori colonization in metaplastic glands of the human stomach. J. Pathol. 197:37-43.
32. Troost, E., Hold, G. L., Smith, M. G., Chow, W. H., Rabkin, C. S., McColl, K. E., El-Omar, E. M. (2003). The role of interleukin-1beta and other potential genetic markers as indicators of gastric cancer risk. Can. J. Gastroenterol. 17 Suppl B:8B-12B.
33. Vinall, L. E., King, M., Green, C. A., Daniels, G., Hilkens, J., Sarner, M. (2002). Swallow DM. Altered expression and allelic association of the hypervariable membrane mucin MUC1 in Helicobacter pylori gastritis. Gastroenterology 123:41-49.
34. Von Mensdorff-Pouilly, S., Gourevitch, M. M., Kenemans, P., Verstraeten, A. A., van Kamp, G. J., Uffelen, K., Snijdewint, F. G. M., Paul, M. A., Meijer, S., Hilgers, J. (1998). An enzyme-linked immunosorbent assay for the measurement of circulating antibodies to polymorphic epithelial mucin (MUC1). Tumor Biol. 19:186-195.
35. Von Mensdorff-Pouilly, S., Snijdewint, F. G. M., Verstraeten, A. A., Verheijen, R. H. M., Kenemans, P. (2000a). Human MUC1 mucin: a multifaceted glycoprotein. J. Biol. Markers 15:343-356.
36. Von Mensdorff-Pouilly, S., Verstraeten, A. A., Kenemans, P., Snijdewint, F. G. M., Kok, A., Van Kamp, G. J., Paul, M. A., Van Diest, P. J., Meijer, S., Hilgers, J. (2000b). Survival in early breast cancer patients is favourably influenced by a natural humoral immune response to polymorphic epitelial mucin (MUC1). J. Clin. Oncol. 18:574-583.
37. Von Mensdorff-Pouilly, S., Petrakou, E., Kenemans, P., Van Uffelen, K., Verstraeten, A. A., Snijdewint, F. G. M., Van Kamp, G. J., Schol, D., Reis, C. A., Price, M. R., Livingston, P. O., Hilgers, J. (2000c). Reactivity of natural and induced human antibodies to MUC1 mucin with MUC1 peptides and N-acetylgalactosamine (GalNAc) peptides. Int. J. Cancer 86:702-712.
38. Von Mensdorf-Pouilly, S., Kinarsky, L., Engelmann, K., Baldus, S. E., Verheijen, R. H., Hollingsworth, M. A., Pisarev, V., Sherman, S., Hanish, F. G. (2005). Sequence variant repeats of MUC1 show higher conformational flexibility, are less densely O-glycosylated and induce differencial B lymphocyte response. Glycobiology 15:735-746.
39. Ye, W., Held, M., Lagergren, J., Engstrand, L., Blot, W. J., McLaughlin, J. K., Nyren, O. (2004). Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia. J. Nat. Cancer Institute 96:388-396.